OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 73 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,721,364 | +39.8% | 301,325 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $2,661,647 | +950.9% | 294,756 | +303.8% | 0.00% | – |
| Q1 2023 | $253,283 | +52.9% | 72,992 | +7.9% | 0.00% | – |
| Q4 2022 | $165,664 | -11.4% | 67,618 | -0.2% | 0.00% | – |
| Q3 2022 | $187,000 | -23.7% | 67,735 | +12.5% | 0.00% | – |
| Q2 2022 | $245,000 | -75.1% | 60,200 | -73.9% | 0.00% | – |
| Q1 2022 | $983,000 | -58.2% | 230,883 | -8.1% | 0.00% | – |
| Q4 2021 | $2,350,000 | -65.4% | 251,108 | +2.0% | 0.00% | -100.0% |
| Q3 2021 | $6,788,000 | +81.8% | 246,265 | +84.5% | 0.00% | 0.0% |
| Q2 2021 | $3,734,000 | -13.5% | 133,442 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $4,317,000 | +546.3% | 130,108 | +835.9% | 0.00% | – |
| Q4 2020 | $668,000 | – | 13,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 3,743,875 | $180,006,000 | 15.43% |
| BVF INC/IL | 6,661,503 | $320,285,000 | 12.60% |
| VR Adviser, LLC | 1,536,193 | $73,860,000 | 10.86% |
| Foresite Capital Management IV, LLC | 818,030 | $39,331,000 | 4.27% |
| Cormorant Asset Management, LP | 3,195,544 | $148,169,000 | 3.53% |
| Vivo Capital, LLC | 1,238,575 | $59,551,000 | 2.66% |
| RA Capital Management | 2,150,404 | $103,391,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 696,191 | $33,473,000 | 0.66% |
| Avoro Capital Advisors LLC | 876,986 | $35,646,000 | 0.61% |
| Avidity Partners Management LP | 270,000 | $12,982,000 | 0.42% |